Axios via Reuters story A medical hygiene product can help reduce or even eliminate the risk of developing the deadly blood cancer that killed more than 70,000 people in the United States in 2015.
Researchers at the University of California, Davis, say the study is the first to show that a topical solution of zinc oxide (ZnO) applied topically to the skin could help patients treat the disease and reduce the risk they might develop.
The study, published online in the journal Clinical Pharmacology and Therapeutics, looked at zinc oxide and zinc chloride (ZcCl) as treatments for patients with blood cancer.
It found that zinc oxide is effective against cancer cells in a number of ways, including blocking the formation of new blood clots, which are the mainstay of the disease.
ZnOs are also known as zinc-silver compounds and are used in a variety of topical products to protect the skin from the sun and prevent sunburn.
Zinc chloride is a chemical found in many common household products and is a skin irritant, but there are few studies on its efficacy against cancer.
To test zinc oxide’s effectiveness in patients with bone marrow disease, researchers injected it into the lungs of patients who were dying of lung cancer and found that the zinc oxide reduced the amount of red blood cells in the lungs.
In a second study, researchers tested zinc oxide in mice with Hodgkin’s lymphoma and found it blocked the growth of the cancer cells and prevented them from multiplying.
The findings suggest zinc oxide could be a promising treatment for cancer.
“The clinical trial results from this study demonstrate that zinc is a promising adjuvant therapy for patients suffering from bone marrow cancer, particularly those with early stage disease,” said Dr. Jeffrey Bresson, an associate professor of dermatology and pathology and a member of the UC Davis Department of Surgery and Surgery Surgery oncology team.
“It may have the potential to be an adjuant therapy for this important type of disease, which is very aggressive.”
A medical hygiene solution for patients who suffer from bone malignancy in the U.s. can be purchased online from the American Cancer Society website.